J I Ventures-Japanese-Origin Innovations ~ Changing the World-Scaling-Up Strategies for
Cultured Meat Production
Kazuki Yamaguchi
Corporate Manager, Organoid Farm Inc.

Organoid Farm Inc.
Our company was established on November 29, 2021, as
an in-house startup project of our parent company, JGC
Japan Corporation, with the goal of commercializing
cultured meat, a meat alternative produced by culturing
animal cells. Our company operates within Shonan
Health Innovation Park (Shonan iPark), one of the largest
life science research facilities in Japan. JGC Japan
Corporation is a Japanese industry-leading engineering
company, and we aim to achieve commercial productionof cultured meat rapidly through the use of our parent
company’s cell culture upscaling technology.

Social issues
It is predicted that the population will continue to increase
until 2050, and that the demand for meat will also increaselinearly. On the other hand, resources such as land andwater are already under strain, and given the environmental
burden, the supply of resources is insufficient withconventional livestock farming alone. In recent years, thesafe production of livestock is also under threat from
Changes in world population and meat demand

Source: OECD-FAO, Agricultural Outlook 2021-2030,
United Nations, World population prospects 2022

events such as climate change, epidemic infectious
diseases and disruptions to the feed supply network. Since
cultured meat is a possible solution to these difficulties,
we have been pursuing technological development
aiming at mass production of cultured meat.

Issues with cultured meat
At present, many companies working on the developmentof cultured meat focus on the approach of aiming for a
product that is as close as possible to existing meatproducts. However, no company has achieved efficient
production of cells that can be used as materials for
cultured meat. Because of this, we can capture a share of
the future upstream cultured meat market by focusing on
mass production of cells that can be used as the raw
materials for cultured meat. From the perspective of mass
production and cost reduction, upscaling will be essential
for making cultured meat available to society. Upscaling
can be achieved by providing the cell strains for producing
cultured meat and culturing processes that we aredeveloping, combined with the plant engineering
technology of our parent company JGC Group.

Current development status
We are focused on developing efficient culturing processes
for bovine cells, and on investigating upscaling from thelab scale to the bench scale. The reason for this focus on
bovine cells is because there is an opportunity for market
entry while cattle are the livestock with the highest
environmental burden, and globally, technology for mass
producing bovine cells has not been established. From theperspective of reducing production costs, we are pursuingdevelopment with the aim of creating seed cells with highculturing efficiency, and associated culturing methods. By
2024.129

Organoid Farm Inc.

Illustration depicting cultured meat production factory

utilizing the technology possessed by the JGC Group,including technology relating to cell culturing (such as
high-precision control technology for culturing conditions
and computational fluid dynamics analysis) andengineering technology for optimizing production
processes, we can rapidly establish mass production
technology for cells. As we have the target of starting
commercial production of cultured meat in 2030, ourcompanies are working in collaboration with the aim ofstarting operation of the first pilot plant in Japan for
cultured meat production, capable of pilot production withtanks with capacities of thousands of liters in around 2027.

Future outlook
For the future, we are looking towards expansion of ourbusiness, including application of our technology to otheranimals such as chicken, pigs and fish, and providing ourcultured food production processes to other companies,
using the range of know-how accumulated through ourresearch and development. As mass production
technology for animal cells can be also applicable toregenerative medicine and pharmaceutical manufacture,
there is a wide spectrum for future business expansion.
Furthermore, since JGC Group has a track record of
constructing plants around the world, we will use thisnetwork to enable global deployment of cultured meatfactories. We, Organoid Farm Inc., are dedicated torealizing a new option of 'cultured meat' for society, under
the principle of 'Unwavering Efforts for a Happier Worldon Earth.' This serves as a sustainable global solution forfood production, ensuring safety and security. Amidst thenumerous challenges we face, we seek partners foradvancing together through global collaboration. We lookforward to hearing from potential partners intrigued by
our initiatives.

お問い合わせJOI 事業企画部
bd@joi.or.jp

Organoid Farm Inc.
E-mail: info@organoid.farm
https://organoid.farm/

Illustration depicting cultured meat products
302024.1